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We have recently demonstrated that human immunodeficiency virus type 1 (HIV-1) Nef is required for enhancing viral
infectivity by increasing the efficiency of viral entry in a producer-cell-dependent manner, suggesting the possible involve-
ment of a cellular factor(s) in the enhancement of viral entry. Moreover, it has been reported that a proline-rich (PxxP) motif
and an Arg-Arg (RR) motif in HIV-1 Nef bind to the SH3 domain of the Src-family tyrosine kinase Hck and to a serine/threonine
kinase, respectively. To address whether these cellular kinase binding motifs, PxxP and RR, could be involved in virus
producer-cell-dependent enhancement of viral entry, we constructed two nef mutant proviral clones in which these motifs
were mutated. The results show that the HIV-1 Nef PxxP motif, which significantly influenced viral infectivity, and the RR motif,
which modestly affected viral infectivity, were both dispensable for enhanced viral entry, thus suggesting that another


























tOne of the accessory genes of human immunodefi-
iency virus type 1 (HIV-1), nef, encodes a 25-/27-kDa
rotein that moderately facilitates the viral replication
ate (13). This positive effect of Nef was clearly demon-
trated in in vivo experiments using SIVmac-infected
hesus monkeys (11) and HIV-1-infected SCID-hu mice
9) and in vitro experiments using quiescent primary T
ymphocytes (19, 25). It was also suggested that Nef
nhances viral particle infectivity (6). Several groups re-
ently suggested that Nef acts at an early step of the viral
eplication cycle, leading to the more efficient completion
f proviral DNA synthesis (4, 23). Similarly, we have
ecently demonstrated that HIV-1 Nef is dispensable for
fficient virion production and is required for enhancing
iral infectivity in a producer-cell-dependent manner (29).
urthermore, we have demonstrated a producer-cell-de-
endent requirement of the Nef protein for efficient entry
f HIV-1 into cells; i.e., nef mutant virus was markedly
mpaired for viral entry efficiency when produced from
EMx174 cells (restrictive cells), but showed an effi-
iency similar to that of wild-type (wt) virus when pro-
uced from certain other human T-cell lines and human
dherent cell lines (permissive cells) (30). This producer
1 Current address: Department of Genetics, Duke University Medical
enter, Durham, NC 27710.
2 To whom correspondence and reprint requests should be ad-
ressed. Fax: 81-3-5285-1189. E-mail: akojima@nih.go.jp.285ell dependency suggests the possible involvement of a
ellular factor(s). Furthermore, it has been reported that a
roline-rich (PxxP) motif in HIV-1 Nef binds to the SH3
omain of the Src-family tyrosine kinase Hck and is
equired for the enhanced growth of Nef1 virus but not
or down-regulation of CD4 (20). The in vivo role of this
otif in pathogenicity remains unclear (5, 10, 12, 15). In
ddition, an Arg–Arg (RR) motif in Nef is important for
inding to serine/threonine kinases (26, 31) and for CD4
own-regulation (3, 8, 31). This association correlates
ith an enhancement in viral infectivity in vitro and with
n vivo pathogenesis, although these correlations are still
ontroversial (17, 22, 31). Therefore, in the present study,
e examined the role of the PxxP and RR motifs in HIV-1
ef in entry enhancement of virions produced from the
estrictive producer cell line CEMx174. The results indi-
ate that, while the PxxP motif significantly influenced
iral infectivity and the RR motif modestly affected it, both
otifs are dispensable for producer-cell-dependent en-
ancement of viral entry. Thus, these findings suggest
hat the producer-cell-dependent effect is mediated by
nother interaction of Nef with a cellular factor(s).
As shown in Fig. 1A, amino acid substitution of Nef in
IV-1 nef mutants pNL-nAxxA and pNL-nRR/AA was per-
ormed by site-directed mutagenesis using the PCR pro-
edure. Pro72 and Pro75, which are known to be essential
or Nef to bind to the SH3 domain of the Src-family
yrosine kinase, Hck (20), were replaced with Ala in0042-6822/99 $30.00
Copyright © 1999 by Academic Press


























































286 RAPID COMMUNICATIONNL-nAxxA, using the primer set nAxxA-S (59-CCAGTCA-
AGCTCAGGTAGCTTTAAGACC-39) and nAxxA-A (59-
GTCTTAAAGCTACCTGAGCTGTGACTGG-39). In pNL-
RR/AA, Arg105 and Arg106, which are required for bind-
ng a cellular serine/threonine kinase (26, 31), were
eplaced with Ala using the primer set nRR/AA-S (59-
ACTCCCAAGCTGCGCAAGATATCC-39) and nRR/AA-A
59-GGATATCTTGCGCAG CTTGGGAGTG-39).
pNL-432 [wt (1)], pNL-Xh [nef frameshift mutant (2)],
NL-nAxxA, and pNL-nRR/AA were introduced individu-
lly into 293T cells by the calcium phosphate coprecipi-
ation method (7) or into CEMx174 cells (21) by the mod-
fied DEAE–dextran method (27). The cells transfected
ith each proviral DNA clone were then subjected to
mmunoblot analysis as described previously (28). It was
onfirmed that wt Nef and the nAxxA and nRR/AA Nef
utants were stably expressed in 293T cells and that Xh
as not (Fig. 1B). Very similar results were also obtained
or transfected CEMx174 cells (data not shown).
Since we have previously found a producer-cell-de-
endent requirement of Nef for efficient viral entry (30),
e next addressed whether the PxxP or RR motif of Nef
s required for efficient viral entry into cells. pNL-wt,
NL-Xh, pNL-nAxxA, pNL-nRR/AA, and the env mutant
NL-kp [as a negative control (2)] were transfected by
he modified DEAE–dextran method into CEMx174 cells,
hich requires Nef to produce fully viral-entry-competent
irions (30). Cell-free virus samples were harvested from
ulture supernatants at 2 days posttransfection and fil-
ered through a 0.45-mm filter. There was no apparent
ifference in the amounts of virions released from the
ransfected CEMx174 cells between wt and nef mutant
lones as judged by p24 antigen capture ELISA (Cellular
roducts Inc., Buffalo, NY) (data not shown). Equal
mounts (20 ng of p24gag) of NL-wt, Xh, nAxxA nRR/AA,
r NL-Kp virions were incubated at 37°C for 1 h in the
FIG. 1. (A) nef mutant proviral HIV-1 clones used in this study. The p
utations of Nef protein were introduced by site-directed mutagenesis
estern blot analysis of Nef expression. Total cellular proteins from 29
y SDS–PAGE and analyzed by Western blotting with anti-HIV-1 p17 1 p
utant).resence of 2 mg/ml of Polybrene with M8166 cells (24),
hich are highly sensitive to HIV-1 infection. Cells were
hen trypsinized to remove viruses nonspecifically at-
ached to the cell surface and lysed in 200 ml of PBS
ontaining 1% Nonidet-P40. For determination of the
mount of p24 antigen internalized into the cells, the total
ell lysates were subjected to p24 antigen capture
LISA. As shown in Fig. 2, we confirmed that Xh virus
erived from restrictive cells entered M8166 cells much
ess efficiently than NL-wt virus, as we reported previ-
usly (30). In contrast, nAxxA and nRR/AA viruses de-
d amino acid sequence of pNL432 Nef is indicated. The amino acid
he PCR procedure. Arrows indicate the amino acid changes made. (B)
s transfected with different nef mutant proviral clones were separated
) or anti-Nef monoclonal (bottom) antibody. Xh, pNL-Xh (nef frameshift
FIG. 2. Entry efficiency of nef mutant viruses derived from restrictive
roducer CEMx174 cells. Virus stocks were prepared by transfection of
EMx174 cells with pNL-wt, pNL-Xh, pNL-nAxxA, pNL-nRR/AA, and
NL-Kp (env mutant). M8166 cells (106 cells) were inoculated at 37°C
or 1 h with viruses (20 ng of p24), washed twice, trypsinized, washed
hree times, and lysed. The p24 antigen contents of the lysates were
uantified by p24 ELISA. The experiments were performed indepen-

















































































287RAPID COMMUNICATIONived from the same cell line revealed no significant
ifference in viral entry efficiency from wt virus. Nonspe-
ific incorporation of Env-deficient kp virions in propor-
ion to input virions was as low as that of NL43delta-env
aused by endocytosis as described recently (18). These
esults indicate that the PxxP and RR motifs of Nef are
ispensable for efficient viral entry into target cells, sug-
esting that another interaction of Nef with a cellular
actor(s) might be involved in this producer-cell-depen-
ent effect of Nef on viral entry.
To determine the infectivity of each nef mutant virus,
eLa-CD4-LTR-b-gal (MAGI) cells were infected, as de-
cribed previously (14), with CEMx174 cell-derived or
93T cell-derived virus stocks containing equal amounts
f p24gag. The restrictive producer CEMx174 cell-de-
ived Xh virus was approximately 10 times less infectious
han the wt virus (Fig. 3A). By contrast and in agreement
FIG. 3. Infectivity of nef mutant virus derived from restrictive
EMx174 cells (A) or derived from permissive 293T cells (B). Infectivity
f cell-free virus samples prepared from transfected cells indicated
as determined by infecting MAGI cells and counting blue foci 48 h
ater. Each infection was performed in triplicate, and the averages with
tandard deviations are shown.ith the previous report using the NL strain (16), there
as only a 2.5-fold difference in infectivity between wt
nd Xh viruses produced from permissive 293T cells (Fig.
B), in which Xh virus acquires entry competence (30).
AxxA virus derived from CEMx174 cells, which exhibited
o defect of viral entry as described above, was less
nfectious than wt virus, but, interestingly, was 2.5 times
ore infectious than entry-defective Xh virus, whereas
93T-derived nAxxA virus showed the same level of in-
ectivity as entry-competent Xh virus. The infectivity of
ntry-competent nRR/AA virus produced from CEMx174
nd 293T cells was moderately lower than that of wt
irus. Overall, these results appear to indicate that Nef
unctions in infectivity enhancement in a producer-cell-
ependent manner, probably at least at two steps in the
iral replication cycle, that is, at viral entry and, as pre-
iously reported (4, 23), at the step of proviral DNA
ynthesis.
We have previously reported that HIV-1 Nef can affect
iral infectivity in a producer-cell-dependent manner, be-
ause the virions grown only in CEMx174 cells were less
nfectious than those produced in another cell line (29).
urthermore, we also demonstrated that HIV-1 Nef is
ritical for efficient viral entry in certain cell types as
onitored by intracellular p24 (30). It may be argued,
owever, that nonspecific vesicular uptake of p24 occurs
ominantly by endocytosis without specific Env–receptor
nteractions (18). Although our entry assay does not mea-
ure cytosolic p24 that represents authentic infection
18), Env–receptor interactions are likely to be involved in
ur system, because similar levels of viral structural
roteins were detected on wt and Nef-deficient virions by
estern blotting as described previously (30). In addi-
ion, the proportion of incorporated Env-deficient kp viri-
ns to input virions (Fig. 2) was as low as that of
L43delta-env virus, which was recently shown to be
ncorporated into CD41 T cells nonspecifically by endo-
ytosis (18). Therefore, the decrease in internal p24 with
ef-deficient Xh virions derived from CEMx174 cells (Fig.
) appears to reflect a defect(s) of Nef-mediated entry
ctivity, if not precisely, to a certain extent and suggests
hat this producer-cell-dependent Nef function might be
ttributed to the interaction of this protein with a cellular
actor(s). Thus, we attempted to determine whether the
ellular kinase binding motifs in HIV-1 Nef, PxxP and RR,
hich have been known to bind to the SH3 domain of the
rc-family tyrosine kinase Hck and to a serine/threonine
inase, respectively, could be required for virus produc-
r-cell-dependent enhancement of viral entry. Our results
resented here showed no significance of these cellular
inase-binding motifs of Nef in the entry enhancement
Fig. 2). This is consistent with our recent results that
rc-family tyrosine kinases regulate HIV-1 infectivity in-
ependent of Nef (27). Furthermore, we found that entry-
efective Xh virus was less infectious than entry-compe-















































288 RAPID COMMUNICATIONrom restrictive cells (Fig. 3A), while entry-competent Xh
irus showed infectivity similar to that of nAxxA virus
hen the virions used were derived from permissive
ells (Fig. 3B). These results could emphasize that Nef
nfluences viral infectivity, at least at two steps in certain
ell types. First, as previously reported (4, 22), Nef is
equired for proviral DNA synthesis. Second, as the
resent findings indicate, this protein is also important
or viral entry in a producer-cell-dependent manner, in-
ependent of the cellular kinase binding motifs, PxxP
nd RR, of Nef, suggesting that another interaction of this
iral protein with a cellular factor(s) is involved in the
roducer-cell-dependent enhancement of viral entry. In
his regard, it would be important to know the relation-
hip of the cell-type-specific stimulation of viral entry to
D4 down-regulation, because the RR motif is required
or CD4 down-regulation (3, 8, 31) but the PxxP motif is
ot (20). Preliminary FACS analysis of CD4 on CEMx174
ells transfected with wt and nef mutant clones did not
rovide informative results, probably because trans-
ected cells were too minor a population for the differ-
nces to be examined. More detailed analysis of the
elationship between Nef functions and the interaction of
ef with another cellular factor(s) in restrictive cells will
llow a better understanding of the mechanism by which
ef influences viral entry.
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